lascondes_28_03

73 / 154

399
REFERENCIAS BIBLIOGRÁFICAS
1. Sanai N, Polley M-Y, Berger MS. Insular glioma resection:
assessment of patient morbidity, survival, and tumor progression.
J Neurosurg. enero de 2010;112(1):1-9.
2. Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard
JL, Bauchet L, et al. Spontaneous and therapeutic prognostic
factors in adult hemispheric World Health Organization Grade
II gliomas: a series of 1097 cases: clinical article. J Neurosurg.
junio de 2013;118(6):1157-68.
3. Afra D, Osztie E. Histologically confirmed changes on CT of
reoperated low-grade astrocytomas. Neuroradiology. noviembre
de 1997;39(11):804-10.
4. Chaichana KL, McGirt MJ, Laterra J, Olivi A, Quiñones-Hinojosa
A. Recurrence and malignant degeneration after resection of
adult hemispheric low-grade gliomas. J Neurosurg. enero de
2010;112(1):10-7.
5. Response rate and prognostic factors of recurrent
oligodendroglioma treated with procarbazine, CCNU, and
vincristine chemotherapy. Dutch Neuro-onco... - PubMed - NCBI
[Internet]. [citado 13 de diciembre de 2016]. Disponible en:
6. Quinn JA, Reardon DA, Friedman AH, Rich JN, Sampson JH,
Provenzale JM, et al. Phase II trial of temozolomide in patients
with progressive low-grade glioma. J Clin Oncol Off J Am Soc Clin
Oncol. 15 de febrero de 2003;21(4):646-51.
7. Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J,
Laigle-Donadey F, et al. Temozolomide for low-grade gliomas:
predictive impact of 1p/19q loss on response and outcome.
Neurology. 22 de mayo de 2007;68(21):1831-6.
8. Shaw EG, Wang M, Coons SW, Brachman DG, Buckner JC, Stelzer
KJ, et al. Randomized trial of radiation therapy plus procarbazine,
lomustine, and vincristine chemotherapy for supratentorial adult
low-grade glioma: initial results of RTOG 9802. J Clin Oncol Off
J Am Soc Clin Oncol. 1 de septiembre de 2012;30(25):3065-70.
9. Buchner et al: Phase III of radiation therapy (RT) with or whithout
procarbazina, CCNU and vincristina (OCV) in low crade glioma
RTOG 9802 wih alliance, ECOG and SWOG. JCO 32,SS 2014
(Suppl bast 2020)
10. Müller K, Gnekow A, Falkenstein F, Scheiderbauer J, Zwiener I,
Pietsch T, et al. Radiotherapy in pediatric pilocytic astrocytomas.
A subgroup analysis within the prospective multicenter study
HITLGG 1996 by the German Society of Pediatric Oncology
and Hematology (GPOH). Strahlenther Onkol Organ Dtsch
Rontgengesellschaft Al. agosto de 2013;189(8):647-55.
11. Brown PD, Anderson SK, Carrero XW, O’Neill BP, Giannini C,
Galanis E, et al. Adult patients with supratentorial pilocytic
astrocytoma: long-term follow-up of prospective multicenter
clinical trial NCCTG-867251 (Alliance). Neuro-Oncol Pract.
diciembre de 2015;2(4):199-204.
12. Ishkanian A, Laperriere NJ, Xu W, Millar B-A, Payne D, Mason
W, et al. Upfront observation versus radiation for adult pilocytic
astrocytoma. Cancer. 1 de septiembre de 2011;117(17):4070-9.
13. Simonova G, Kozubikova P, Liscak R, Novotny J. Leksell Gamma
Knife treatment for pilocytic astrocytomas: long-term results. J
Neurosurg Pediatr. julio de 2016;18(1):58-64.
14. Hallemeier CL, Pollock BE, Schomberg PJ, Link MJ, Brown
PD, Stafford SL. Stereotactic radiosurgery for recurrent or
unresectable pilocytic astrocytoma. Int J Radiat Oncol Biol Phys.
1 de mayo de 2012;83(1):107-12.
15. Van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S,
Hoang-Xuan K, et al. Long-term efficacy of early versus delayed
radiotherapy for low-grade astrocytoma and oligodendroglioma
in adults: the EORTC 22845 randomised trial. Lancet Lond Engl.
17 de septiembre de 2005;366(9490):985-90.
16. Cairncross G, Wang M, Shaw E, Jenkins R, Brachman D, Buckner
J, et al. Phase III trial of chemoradiotherapy for anaplastic
oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol
Off J Am Soc Clin Oncol. 20 de enero de 2013;31(3):337-43.
17. Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR,
Barger GR, et al. Radiation plus Procarbazine, CCNU, and
Vincristine in Low-Grade Glioma. N Engl J Med. 7 de abril de
2016;374(14):1344-55.
18. Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker
PA, Sicotte H, et al. Glioma Groups Based on 1p/19q, IDH, and
TERT Promoter Mutations in Tumors. N Engl J Med. 25 de junio
de 2015;372(26):2499-508.
19. Keles GE, Chang EF, Lamborn KR, Tihan T, Chang C-J, Chang
SM, et al. Volumetric extent of resection and residual contrast
enhancement on initial surgery as predictors of outcome in adult
patients with hemispheric anaplastic astrocytoma. J Neurosurg.
julio de 2006;105(1):34-40.
20. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ.
Fluorescence-guided resection of glioblastoma multiforme by
using 5-aminolevulinic acid-induced porphyrins: a prospective
study in 52 consecutive patients. J Neurosurg. diciembre de
2000;93(6):1003-13.
21. Yamamoto M, Iwaasa M, Nonaka M, Tsugu H, Nabeshima K,
Fukushima T. Efficacy and feasibility of procarbazine, ranimustine
and vincristine chemotherapy, and the role of surgical resection
in anaplastic oligodendroglioma. Anticancer Res. diciembre de
2005;25(6A):3715-23.
22. Jeremic B, Shibamoto Y, Gruijicic D, Milicic B, Stojanovic M,
Nikolic N, et al. Combined treatment modality for anaplastic
oligodendroglioma: a phase II study. J Neurooncol. junio de
1999;43(2):179-85.
23. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella
F, Reulen H-J, et al. Fluorescence-guided surgery with
Los autores declaran no tener conflictos de interés, en relación a este artículo.
[MANEJO DE LOS TUMORES CEREBRALES ASTROCÍTICOS Y OLIGODENDROGLIALES - Dr. Enrique Concha y cols.]